Low Serum Albumin Is Associated with Poor Prognosis in Patients Receiving Peritoneal Dialysis Treatment

BACKGROUND: The number of patients receiving dialysis treatment is sustainably increasing, especially peritoneal dialysis. OBJECTIVES: It is necessary to find out potential factors that may indicate the prognosis of patients receiving peritoneal dialysis treatment. METHODS: This study retrospectivel...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yanan, Cai, Jiajie, Shi, Chunxia, Liu, Conghui, Zhou, Jingjing, Li, Zhongxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038379/
https://www.ncbi.nlm.nih.gov/pubmed/35480153
http://dx.doi.org/10.1155/2022/7660806
Descripción
Sumario:BACKGROUND: The number of patients receiving dialysis treatment is sustainably increasing, especially peritoneal dialysis. OBJECTIVES: It is necessary to find out potential factors that may indicate the prognosis of patients receiving peritoneal dialysis treatment. METHODS: This study retrospectively involved 325 patients who received peritoneal dialysis treatment. RESULTS: Low serum albumin (HR = 2.254; 95% CI: 1.534–3.311; P < 0.001) and high FBG (Fasting blood glucose) (HR = 1.474; 95% CI: 1.025–2.120; P=0.037) were risk factors for death in patients receiving peritoneal dialysis treatment. Serum albumin (AUC = 0.683; P < 0.001) and creatinine (AUC = 0.625; P < 0.001) exhibited value of prognosis prediction. Both high FBG (P=0.005) and low albumin (P < 0.001) were associated with poor prognosis, and low albumin predicted poorer survival. CONCLUSIONS: Low serum albumin and high fasting blood glucose were risk factors and associated with poor prognosis. Low albumin has a potential in predicting the prognosis of patients receiving peritoneal dialysis treatment.

Ejemplares similares